Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada

Antimicrobial Agents and Chemotherapy
David A BoydMichael R Mulvey

Abstract

A major outbreak involving an Escherichia coli strain that was resistant to expanded-spectrum cephalosporins occurred in Toronto and surrounding regions in 2000 to 2002. We report the complete sequence of a plasmid, pC15-1a, that was found associated with the outbreak strain. Plasmid pC15-1a is a circular molecule of 92,353 bp consisting of two distinct regions. The first is a 64-kb region that is essentially homologous to the non-R-determinant region of plasmid R100 except for several point mutations, a few small insertions and deletions, and the absence of Tn10. The second is a 28.4-kb multidrug resistance region (MDR) that has replaced the R-determinant region of the R100 progenitor and consists mostly of transposons or partial transposons and five copies of the insertion element IS26. All drug resistance genes found in pC15-1a, including the beta-lactamase genes bla(CTX-M-15), bla(OXA-1), and bla(TEM-1), the tetracycline resistance gene tetA, and aminoglycoside resistance genes aac(6')-Ib and aac(3)-II, are located in the MDR. The bla(CTX-M-15) gene was found downstream of ISEcp1as part of a transposition unit, as determined from the surrounding sequence. Examination of the plasmids from CTX-M-15-harboring strains isolated ...Continue Reading

References

May 15, 1991·The Biochemical Journal·R P AmblerS G Waley
May 19, 1972·Science·J E Davies, R Rownd
May 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M T Nüesch-InderbinenF H Kayser
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
May 1, 1999·Antimicrobial Agents and Chemotherapy·T NaasP Nordmann
Mar 18, 2000·International Journal of Antimicrobial Agents·L S TzouvelekisN J Legakis
Dec 20, 2000·Bioinformatics·K RutherfordB Barrell
Jun 1, 2001·Emerging Infectious Diseases·B SwaminathanUNKNOWN CDC PulseNet Task Force
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·R BonnetJ Sirot
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Christel HumeniukAlain Philippon
Sep 3, 2002·The Journal of Antimicrobial Chemotherapy·Anna BaraniakMarek Gniadkowski
May 31, 2003·The Journal of Antimicrobial Chemotherapy·R BonnetJ Sirot
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Minggui WangDavid C Hooper
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Dec 1, 1960·Biochemical and Biophysical Research Communications·R NAKAYAY MURATA
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·R Bonnet
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Michael R MulveyUNKNOWN Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada

❮ Previous
Next ❯

Citations

Nov 13, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L DrieuxV Jarlier
Jul 31, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joshua T FreemanRoderick B Ellis-Pegler
May 21, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rumyana MarkovskaAdolf Bauernfeind
May 5, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Safia DahmenGuillaume Arlet
Feb 4, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Samia RéjibaAmel Kechrid
Feb 2, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Umaer Naseer, Arnfinn Sundsfjord
Jan 11, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Zaket Baba Ahmed-Kazi TaniMourad Drissi
Oct 22, 2008·The Journal of Antimicrobial Chemotherapy·Geraldine MarcadéGuillaume Arlet
May 29, 2010·The Journal of Antimicrobial Chemotherapy·Basma MnifGuillaume Arlet
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Laura VillaAlessandra Carattoli
Nov 18, 2010·The Journal of Antimicrobial Chemotherapy·Benjamin A RogersDavid L Paterson
Aug 30, 2008·Antimicrobial Agents and Chemotherapy·Zhiyong ZongJonathan R Iredell
Apr 15, 2009·Antimicrobial Agents and Chemotherapy·Etienne RuppéBernard Rouveix
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Katie L HopkinsAlessandra Carattoli
Aug 9, 2007·Antimicrobial Agents and Chemotherapy·Sally R Partridge
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Maria Sjölund-KarlssonJean M Whichard
Jun 27, 2007·Antimicrobial Agents and Chemotherapy·Corinne ArpinClaudine Quentin
Mar 25, 2009·Antimicrobial Agents and Chemotherapy·Alessandra Carattoli
Mar 30, 2011·Antimicrobial Agents and Chemotherapy·Gisele PeiranoJohann D D Pitout
Dec 12, 2012·Antimicrobial Agents and Chemotherapy·Monika DolejskaAlessandra Carattoli
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Johann D D PitoutJames R Johnson
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Timothy J JohnsonLisa K Nolan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.